Castleman Disease

Hematol Oncol Clin North Am. 2018 Feb;32(1):xiii-xiv. doi: 10.1016/j.hoc.2017.10.001.

Authors

Frits van Rhee¹, Nikhil C Munshi²

Affiliations

¹ Myeloma Institute, University of Arkansas for Medical Sciences, 4301 West Markham, #816, Little Rock, AR 72205, USA. Electronic address: vanrheefrits@uams.edu.
² Dana Farber Cancer Institute, VA Boston Healthcare System, Harvard Medical School, 450 Brookline Avenue, M230, Boston, MA 02215, USA. Electronic address: nikhil_munshi@dfci.harvard.edu.

PMID: 29157623
DOI: 10.1016/j.hoc.2017.10.001

No abstract available

Publication types

Editorial
Introductory Journal Article

MeSH terms

Castleman Disease* / diagnosis
Castleman Disease* / epidemiology
Castleman Disease* / etiology
Castleman Disease* / therapy
Humans